This website is being reviewed for updates. Some information is offline. We apologize for any inconvenience.
Skip to main content
Rural Health Information Hub
Rural Health Information Hub

Rural Health
News by Topic: Pharmacy and prescription drugs

Jan 2, 2026 - Announces that the COVID-19 public health emergency telemedicine flexibilities have been extended until December 31, 2026. Notes that the flexibility increases access to prescriptions for controlled medications for rural residents and others.
Source: U.S. Department of Health and Human Services
Dec 31, 2025 - The Drug Enforcement Administration (DEA) and the U.S. Department of Health and Human Services (HHS) is issuing a temporary rule to extend certain exceptions to existing DEA regulations implemented in March 2020 because of the COVID-19 Public Health Emergency (COVID-19 PHE). The full set of telemedicine flexibilities regarding the prescription of controlled medications that were in place during the COVID-19 PHE as outlined in the Third Temporary Rule will remain in place through December 31, 2026. This rule is effective January 1, 2026, through December 31, 2026.
Source: Federal Register
Dec 26, 2025 - Highlights proposed legislation in Ohio that would allow pharmacists to prescribe and dispense certain medications. Notes the potential impact on rural residents with more barriers in accessing healthcare.
Source: The Center Square
Dec 23, 2025 - Notice from the Centers for Medicare & Medicaid Services (CMS) seeking comments on a proposed rule implementing the Global Benchmark for Efficient Drug Pricing Model ("GLOBE Model"), a new Medicare payment model under section 1115A of the Social Security Act. The GLOBE Model would test whether a payment model that uses an alternative method for calculating Part B inflation rebate amounts for certain separately payable Part B drugs and biological products reduces costs for Medicare fee-for service (FFS) beneficiaries and the Medicare program while preserving quality of care. Comments are due by February 23, 2026.
Source: Federal Register
Dec 23, 2025 - Notice from the Centers for Medicare & Medicaid Services (CMS) seeking comments on a proposed rule implementing the Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model to test a new Medicare payment model under section 1115A of the Social Security Act. The model proposes a test of an alternative payment method for calculating inflation rebates for certain Part D drugs and biological products. The proposed GUARD Model would test whether changing the calculation of the Part D inflation rebate would reduce costs for the Medicare program while preserving or enhancing quality of care for Part D enrollees. Comments are due by February 23, 2026.
Source: Federal Register
Dec 22, 2025 - Notice from the Centers for Medicare & Medicaid Services (CMS) is seeking comments on the following information collections: 1) External Quality Review (EQR) of Medicaid and Children's Health Insurance Program (CHIP) Managed Care, EQR Protocols, and Supporting Regulations; and 2) Medicaid Drug Program. Comments are due by February 20, 2026.
Source: Federal Register
Dec 22, 2025 - Notice from the Centers for Medicare & Medicaid Services (CMS) is seeking comments on the following information collections: 1) CMS Plan Benefit Package (PBP) and Formulary CY 2027; and 2) Medicare Part C and Part D Program Audit and Industry-Wide Part C Timeliness Monitoring Project (TMP) Protocols. Comments are due by February 20, 2026.
Source: Federal Register
Dec 17, 2025 - The Centers for Medicare & Medicaid Services is seeking comments on an information collection titled "Requirement for Electronic Prescribing for Controlled Substances (EPCS) for a Covered Part D Drug Under a Prescription Drug Plan or an MA-PD Plan." The EPCS exception requires a waiver if a prescriber is unable to conduct EPCS due to circumstances outside the prescribers control. Comments are due January 16, 2026.
Source: Federal Register
Dec 16, 2025 - Notice from the Centers for Medicare & Medicaid Services seeking comments on the following information collections: 1) Model Medicare Advantage and Medicare Prescription Drug Plan Individual Enrollment Request Form; and 2) Annual Notice of Change and Evidence of Coverage for Applicable Integrated Plans in States that Require Integrated Materials. Comments are due by January 15, 2026.
Source: Federal Register